• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境调控纳米医学设计以对抗多药耐药肿瘤。

Tumor microenvironment-regulating nanomedicine design to fight multi-drug resistant tumors.

机构信息

Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, People's Republic of China.

Breast Center, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.

出版信息

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Jan;15(1):e1842. doi: 10.1002/wnan.1842. Epub 2022 Aug 21.

DOI:10.1002/wnan.1842
PMID:35989568
Abstract

The tumor microenvironment (TME) is a very cunning system that enables tumor cells to escape death post-traditional antitumor treatments through the comprehensive effect of different factors, thereby leading to drug resistance. Deep insights into TME characteristics and tumor resistance encourage the construction of nanomedicines that can remodel the TME against drug resistance. Tremendous interest in combining TME-regulation measurement with traditional tumor treatment to fight multidrug-resistant tumors has been inspired by the increasing understanding of the role of TME reconstruction in improving the antitumor efficiency of drug-resistant tumor therapy. This review focuses on the underlying relationships between specific TME characteristics (such as hypoxia, acidity, immunity, microorganisms, and metabolism) and drug resistance in tumor treatments. The exciting antitumor activities strengthened by TME regulation are also discussed in-depth, providing solutions from the perspective of nanomedicine design. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Nanotechnology Approaches to Biology > Nanoscale Systems in Biology.

摘要

肿瘤微环境(TME)是一个非常狡猾的系统,它通过不同因素的综合作用,使肿瘤细胞能够在传统抗肿瘤治疗后免于死亡,从而导致耐药性。深入了解 TME 特征和肿瘤耐药性,鼓励构建能够重塑 TME 以抵抗耐药性的纳米药物。随着对 TME 重构在提高耐药性肿瘤治疗抗肿瘤效率中的作用的认识不断加深,人们对将 TME 调节测量与传统肿瘤治疗相结合以对抗多药耐药肿瘤的兴趣大增。本综述重点关注特定 TME 特征(如缺氧、酸度、免疫、微生物和代谢)与肿瘤治疗中耐药性之间的潜在关系。还深入讨论了 TME 调节增强的令人兴奋的抗肿瘤活性,从纳米医学设计的角度提供了解决方案。本文属于以下类别: 治疗方法和药物发现 > 新兴技术 治疗方法和药物发现 > 用于肿瘤疾病的纳米医学 纳米技术在生物学中的应用 > 生物学中的纳米级系统

相似文献

1
Tumor microenvironment-regulating nanomedicine design to fight multi-drug resistant tumors.肿瘤微环境调控纳米医学设计以对抗多药耐药肿瘤。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Jan;15(1):e1842. doi: 10.1002/wnan.1842. Epub 2022 Aug 21.
2
Remodeling tumor microenvironment with nanomedicines.用纳米药物重塑肿瘤微环境。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Nov;13(6):e1730. doi: 10.1002/wnan.1730. Epub 2021 Jun 14.
3
Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple-negative breast cancer.纳米颗粒药物传递系统对肿瘤微环境的响应:在三阴性乳腺癌治疗中的有前途的选择。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Mar-Apr;16(2):e1950. doi: 10.1002/wnan.1950.
4
Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.联合癌症治疗——攻克肿瘤微环境的复杂性。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Sep;13(5):e1704. doi: 10.1002/wnan.1704. Epub 2021 Feb 9.
5
Improved cancer immunotherapy strategies by nanomedicine.纳米医学改善癌症免疫疗法策略。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 May-Jun;15(3):e1873. doi: 10.1002/wnan.1873. Epub 2022 Dec 28.
6
Engineering metal-phenolic networks for enhancing cancer therapy by tumor microenvironment modulation.通过肿瘤微环境调节增强癌症治疗的工程金属-酚醛网络。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 May-Jun;15(3):e1864. doi: 10.1002/wnan.1864. Epub 2022 Nov 5.
7
Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.纳米医学在肿瘤微环境和癌症耐药性中的响应作用。
Curr Med Chem. 2023;30(29):3335-3355. doi: 10.2174/0929867329666220922111336.
8
Organoids technology for advancing the clinical translation of cancer nanomedicine.用于推进癌症纳米医学临床转化的类器官技术。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Sep-Oct;15(5):e1892. doi: 10.1002/wnan.1892. Epub 2023 Apr 23.
9
Strategies targeting tumor immune and stromal microenvironment and their clinical relevance.针对肿瘤免疫和基质微环境的策略及其临床相关性。
Adv Drug Deliv Rev. 2022 Apr;183:114137. doi: 10.1016/j.addr.2022.114137. Epub 2022 Feb 7.
10
Cell surface-nanoengineering for cancer targeting immunoregulation and precise immunotherapy.细胞表面纳米工程用于癌症靶向免疫调节和精确免疫治疗。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Jul-Aug;15(4):e1875. doi: 10.1002/wnan.1875. Epub 2022 Dec 26.

引用本文的文献

1
Synthesis, Characterization, HSA/DNA Binding, and Cytotoxic Activity of [RuCl(η--cymene)(bph-κ)] Complex.[RuCl(η-对异丙基苯)(bph-κ)]配合物的合成、表征、与人血清白蛋白/DNA的结合及细胞毒性活性
Molecules. 2025 Jul 23;30(15):3088. doi: 10.3390/molecules30153088.
2
Removing Barriers to Tumor 'Oxygenation': Depleting Glutathione Nanozymes in Cancer Therapy.消除肿瘤“氧合”障碍:癌症治疗中消耗谷胱甘肽的纳米酶
Int J Nanomedicine. 2025 May 1;20:5613-5643. doi: 10.2147/IJN.S515734. eCollection 2025.
3
Role of the TME in immune checkpoint blockade resistance of non-small cell lung cancer.
肿瘤微环境在非小细胞肺癌免疫检查点阻断耐药中的作用
Cancer Drug Resist. 2024 Dec 16;7:52. doi: 10.20517/cdr.2024.166. eCollection 2024.
4
Engineering Stimuli-Responsive Materials for Precision Medicine.用于精准医学的工程化刺激响应材料。
Small. 2025 Jan;21(1):e2406439. doi: 10.1002/smll.202406439. Epub 2024 Oct 23.
5
Delivery of Avocado Seed Extract Using Novel Charge-Switchable Mesoporous Silica Nanoparticles with Galactose Surface Modified to Target Sorafenib-Resistant Hepatocellular Carcinoma.新型电荷可转换介孔硅纳米粒子递送鳄梨仁提取物,并用半乳糖表面修饰以靶向索拉非尼耐药肝癌。
Int J Nanomedicine. 2024 Oct 14;19:10341-10365. doi: 10.2147/IJN.S478574. eCollection 2024.
6
Targeted Drug Delivery Strategies for the Treatment of Hepatocellular Carcinoma.针对肝细胞癌的靶向药物递送策略。
Molecules. 2024 Sep 16;29(18):4405. doi: 10.3390/molecules29184405.
7
The application of bacteria-nanomaterial hybrids in antitumor therapy.细菌-纳米材料杂合体在抗肿瘤治疗中的应用。
J Nanobiotechnology. 2024 Sep 4;22(1):536. doi: 10.1186/s12951-024-02793-x.
8
Writers, readers, and erasers RNA modifications and drug resistance in cancer.RNA 修饰与癌症的药物耐药性:作者、读者和橡皮擦
Mol Cancer. 2024 Aug 30;23(1):178. doi: 10.1186/s12943-024-02089-6.
9
Photodynamic therapy for cancer: mechanisms, photosensitizers, nanocarriers, and clinical studies.癌症的光动力疗法:作用机制、光敏剂、纳米载体及临床研究。
MedComm (2020). 2024 Jun 22;5(7):e603. doi: 10.1002/mco2.603. eCollection 2024 Jul.
10
Fluorinated Cell-Penetrating Peptide for Co-Delivering siHIF-1α and Sorafenib to Enhance In Vitro Anti-Tumor Efficacy.用于共递送siHIF-1α和索拉非尼以增强体外抗肿瘤功效的氟化细胞穿透肽
Pharmaceutics. 2023 Dec 16;15(12):2789. doi: 10.3390/pharmaceutics15122789.